Topics

Michael Wong is an Emeritus Board Member of the Harvard Business School Healthcare Alumni Association.

Articles

Dr. Liz Kwo of Everly Health outlines 2023 predictions for AI, including how it can be beneficial to patients

Creating Scalable Solutions in a Cost-conscious Healthcare Ecosystem 

Action enables the company to begin offering its unit-load device for shipments 

A New Player in Cold Chain Air Freight Containers, Swiss Airtainer, Wins EASA Approval

Semiannual update includes better revenue forecasting and state reporting

Model N Updates Its Revenue-Management Solution for Commercial Pharma Practices

Observations from recent digital health events and a glimpse of what’s ahead—from Milan to Boca Raton

Exploring the Digital Therapeutics Landscape

How taking steps to incorporate data into all regulatory and labeling operations helps firms avoid retroactively planning to recapture information


Benefits of Structured Content in Preparing Data for Regulatory Submissions

Dr. Troy Sarich of Janssen reveals the company's approach to tackling financial challenges as they pertain to tech

Investing in Success

Featuring manufacturing technology, the new facility supports medicines supply chain resilience 

USP Launches R&D Lab

Stakeholders are investing heavily in their ability to curate appropriate data sets and devise advanced data-analytics capabilities to harness real-world evidence (RWE) across the entire pharma lifecycle—from drug discovery and development through product launch and commercialization

Pharma and RWE: Hitting Its Stride

How to make commercial AI actionable in the last mile, helping to better realize      data science investment and improve customer engagement

'Next-Best-Action' for Data Analytics

How biopharma commercial teams can leverage machine learning techniques to improve targeting of HCPs and patients

Data and Technology